Literature DB >> 1375747

Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat.

C Fernández-del Castillo1, J Schmidt, D W Rattner, K Lewandrowski, C C Compton, A Jehanli, G Patel, J Hermon-Taylor, A L Warshaw.   

Abstract

Trypsinogen activation peptides (TAP) were quantified by radioimmunoassay in blood, urine, and peritoneal exudate of rats with experimental pancreatitis. Forty-four animals were studied, comprising a control group and four different induction techniques (cerulein, cerulein plus either 2- or 10-min intraductal glycodeoxycholic acid [GDOC] infusion, and cerulein plus intraductal GDOC with enterokinase [EK]). Significantly higher TAP concentrations were found at 6 h (or at death) in plasma and ascites of all pancreatitis groups compared with controls. TAP quantitation in hourly urine samples demonstrated significantly higher concentrations from the third hour onward in the most severe groups and from the fourth hour onward in the cerulein-treated rats. All nonsurviving rats had a plasma TAP of greater than 2.5 nM/L, whereas only 1 of 34 surviving animals had such a concentration (p less than 0.001). A significant stepwise increase in total TAP in ascites was found when comparing the cerulein group, the two GDOC groups, and the EK group (p less than 0.001). Chromatography of samples with a high TAP content demonstrated comigration with synthetic TAP. We conclude that free TAP are present in blood, urine, and peritoneal exudate of rats with experimental pancreatitis of different pathogenesis and that the amount of TAP may be indicative of the severity of the disease process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375747     DOI: 10.1097/00006676-199205000-00001

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

1.  Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

Authors:  S Tenner; C Fernandez-del Castillo; A Warshaw; W Steinberg; J Hermon-Taylor; J E Valenzuela; M Hariri; M Hughes; P A Banks
Journal:  Int J Pancreatol       Date:  1997-04

2.  Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis.

Authors:  D I Heath; C Wilson; A M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

3.  Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.

Authors:  Heidi S Allen; Jörg Steiner; John Broussard; Caroline Mansfield; David A Williams; Boyd Jones
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

4.  Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic injury in necrotizing pancreatitis of the rat.

Authors:  J Schmidt; E Ryschich; H P Sinn; S Maksan; C Herfarth; E Klar
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

5.  Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis.

Authors:  G Alsfasser; B Antoniu; S P Thayer; A L Warshaw; C Fernández-del Castillo
Journal:  Pancreatology       Date:  2005-03-15       Impact factor: 3.996

6.  The relative safety of MRI contrast agent in acute necrotizing pancreatitis.

Authors:  J Werner; J Schmidt; A L Warshaw; M M Gebhard; C Herfarth; E Klar
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

7.  Intravenous contrast medium aggravates the impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat.

Authors:  J Schmidt; H G Hotz; T Foitzik; E Ryschich; H J Buhr; A L Warshaw; C Herfarth; E Klar
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

8.  Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis.

Authors:  T Foitzik; H G Hotz; J Schmidt; E Klar; A L Warshaw; H J Buhr
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

9.  Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation.

Authors:  K W Simpson; N Beechey-Newman; C R Lamb; J B Smyth; G Hughes; K Coombe; N Sumar; J Hermon-Taylor
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

10.  Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis.

Authors:  K Mithöfer; C Fernández-del Castillo; T W Frick; T Foitzik; D G Bassi; K B Lewandrowski; D W Rattner; A L Warshaw
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.